nifedipine has been researched along with seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dou, W; Hu, J; Shen, H; Sun, J | 1 |
1 other study(ies) available for nifedipine and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide
| Article | Year |
|---|---|
A comparison of the effects of nifedipine, verapamil, and low-molecular-weight heparin on SLIGRL-NHâ‚‚-induced calcium influx through proteinase-activated receptor 2 activation.
Topics: Calcium; Calcium Channel Blockers; HEK293 Cells; Heparin, Low-Molecular-Weight; Humans; Nifedipine; Oligopeptides; Receptor, PAR-2; Verapamil | 2014 |